Table 3.
Clinicopathological features of cutaneous CVC, GCA, and PEH.
| Clinicopathological features | VC, N = 21, n (%) | GCA, N = 21, n (%) | PEH, N = 21, n (%) | Value of p |
|---|---|---|---|---|
| Exudation and crusting | 21/21 (100) | 10/21 (48) | 14/21 (67) | p < 0.01 |
| Induration | 21/21 (100) | 3/21 (14) | 16/21 (76) | p < 0.01 |
| Irregular borders | 21/21 (100) | 7/21 (33) | 17/21 (81) | p < 0.01 |
| Warty surface | 19/21 (90) | 21/21 (100) | 5/21 (24) | p < 0.01 |
| Growth pattern | p < 0.01 | |||
| Endophytic | 0/21 (0) | 0/21 (0) | 18/21 (86) | |
| Exophytic | 0/21 (0) | 21/21 (100) | 0/21 (0) | |
| Exo-endophytic | 21/21 (100) | 0/21 (0) | 3/21 (14) | |
| Koilocytotic cells | 0/21 (0) | 19/21 (90) | 1/21 (5) | p < 0.01 |
| The depth of acanthosis | p < 0.01 | |||
| Papillary dermis | 0/21 (0) | 19/21 (90) | 18/21 (86) | |
| Reticular dermis | 21/21 (100) | 2/21 (10) | 3/21 (14) | |
| Morphologic features of acanthosis | p < 0.01 | |||
| Blunt with pushing margins | 18/21 (86) | 1/21 (5) | 2/21 (10) | |
| Papillomatous | 0/21 (0) | 17/21 (81) | 1/21 (5) | |
| Irregular | 3/21 (14) | 3/21 (14) | 18/21 (86) | |
| Severe keratinization | 21/21 (100) | 2/21 (10) | 3/21 (14) | p < 0.01 |
| Degree of dermal inflammation | p < 0.01 | |||
| Mild | 0/21 (0) | 11/21 (52) | 3/21 (14) | |
| Moderate | 5/21 (24) | 7/21 (33) | 11/21 (52) | |
| Severe | 16/21 (76) | 3/21 (14) | 7/21 (33) | |
| Basal cell mild atypia | 10/21 (48) | 2/21 (10) | 9/21 (43) | p = 0.017 |
CVC, cutaneous verrucous carcinoma; GCA, giant condyloma acuminatum; PEH, pseudoepitheliomatous hyperplasia.